Clinical and pathogenetic importance of hormonal natriuretic peptides in gout


  • O.V. Syniachenko Donetsk National Medical University, Lyman, Ukraine
  • D.M. Fedorov Donetsk National Medical University, Lyman, Ukraine
  • M.V. Yermolaieva Donetsk National Medical University, Lyman, Ukraine
  • V.V. Pylypenko Donetsk National Medical University, Lyman, Ukraine



gout, course, pathogenesis, natriuretic pep- tides


Background. In addition to purine metabolism disorders, systems of pro-inflammatory cytokines, matrix metalloproteinases and eicosanoids, various medium molecular weight compounds can participate in the pathogenesis of gout, including natriuretic peptides (atrial — ANP, cerebral — BNP), but their significance needs further exploration. The purpose of the study was to evaluate the clinical and pathogenetic significance of ANP and BNP in cases of joint, kidney and heart disease in patients with gout. Materials and methods. One hundred five patients with primary gout were examined, 92 % of them were men and 8 % — women aged 26 to 76 years (51 years on average), and women were 8 years older. The average duration of the disease was 12 years. The first sign of gout in 91 % of patients was the joint crisis, and in the remaining cases — renal colic. The ratio of the incidence of intermittent and chronic forms of arthritis was 2 : 1, latent nephropathy occurred in 66 % of cases, urolithiasis — in 34 %, and the ratio of stages I, II, III and IV of chronic kidney di-sease was 4 : 2 : 1 : 1. The level of serum natriuretic peptides was studied by the method of enzyme-linked immunosorbent assay (PR2100 analyzer, Sanofi Diagnostic Pasteur, France). Results. Primary gout occurs with impaired metabolism of uric acid, oxypurinol, purine bases, purine metabolism enzymes and purine-associated trace elements (molybdenum, lead), the integral changes of which depend on the type of joint and kidney syndromes, the presence of peripheral and bone tofi, as well as the stage of chronic kidney disease. They determine bone-destructive articular lesions, and are prognostic factors for the severity of arthropathy and nephropathy. In addition to disorders of purine metabolism, patients with gout (compared with healthy people in the control group) have a significant increased blood concentrations of ANP — by 31 % (5.50 ± 0.18 pg/ml) and BNP — by 79 % (12.20 ± 1.16 pg/ml), which were found in 57 and 52 % of examined patients, respectively. It is correlated with the severity of joint syndrome, the presence of peripheral and bone tofi, and there are close relationships of medium molecular weight hormone peptides with bone-destructive articular changes, with parameters of purine metabolism and integral level of medium weight molecules which belong to different fractions, and indicators of ANP are of practical value. The type of nephropathy (latent, urolithiasis) and the stage of chronic kidney disease influence the integral state of ANP and BNP in the body of gout patients. Meanwhile, the parameters of urinary syndrome, the development of urolithiasis, nephrocalcinosis and nephrocystosis depend on the levels of these peptides. The effect of ANP level on the formation of diastolic dysfunction of the left ventricle was established, and BNP influence the development of disorders of cardiac conduction and an increase in the size of heart chambers. The level of ANP > 6 pg/ml in gouty arthritis is recommended for assessing the severity of articular narrowing, and this indicator is also a risk factor for decreased kidney function. Conclusions. The studied hormonal natriuretic peptides do not only participate in the pathogenesis of gouty arthritis, nephropathy and cardiopathy, but also are of prognostic significance.


Download data is not yet available.


Gonzalez-Rozas M, Prieto de Paula JM, Franco Hidalgo S, Lopez Pedreira MR. Chronic tophaceous gout. Semergen. 2013 Sep;39(6):e29-34. doi: 10.1016/j.semerg.2012.05.004.

Martillo MA, Nazzal L, Crittenden DB. The crystallization of monosodium urate. Curr Rheumatol Rep. 2018;16(2):400-5. doi: 10.1136/jim-2018-000728.

Steiger S, Harper JL. Mechanisms of spontaneous resolution of acute gouty inflammation. Curr Rheumatol Rep. 2014 Jan;16(1):392. doi: 10.1007/s11926-013-0392-5.

Bolzetta F, Veronese N, Manzato E, Sergi G. Chronic gout in the elderly. Aging Clin Exp Res. 2013 May;25(2):129-37. doi: 10.1007/s40520-013-0031-z.

Manara M, Bortoluzzi A, Favero M, et al. Italian society of rheumatology recommendations for the management of gout. Reumatismo. 2018;65(1):4-21. doi: 10.1074/jbc.M115.649855.

Manger B. Gout and other crystal-induced arthritides. Dtsch Med Wochenschr. 2012 Aug;137(31-32):1579-81. doi: 10.1055/s-0032-1305108.

Hayward RA, Rathod T, Roddy E, Muller S, Hider SL, Mallen CD. The association of gout with socioeconomic status in primary care: a cross-sectional observational study. Rheumatology (Oxford). 2013 Nov;52(11):2004-8. doi: 10.1093/rheumatology/ket262.

Kuo CF, Grainge MJ, See LC, et al. Epidemiology and management of gout in Taiwan: a nationwide population study. Arthritis Res Ther. 2016;(17):13-9. doi: 10.1186/s13075-015-0522-8.

Crişan TO, Cleophas MCP, Novakovic B, et al. Uric acid priming in human monocytes is driven by the AKT-PRAS40 autophagy pathway. Proc Natl Acad Sci USA. 2017;114(21):5485-90. doi: 10.1073/pnas.1620910114.

ee JH, Yang JA, Shin K, et al. Elderly patients exhibit stronger inflammatory responses during gout attacks. J Korean Med Sci. 2017;32(12):1967-73. doi: 10.3346/jkms.2017.32.12.1967.

Tao JH, Cheng M, Tang JP, et al. Single nucleotide polymorphisms associated with P2X7R function regulate the onset of gouty arthritis. PLoS One. 2017;12(8):e0181685. doi: 10.1371/journal.pone.0181685.

Vanheule V, Boff D, Mortier A, et al. CXCL9-derived peptides differentially inhibit neutrophil migration in vivo through interference with glycosaminoglycan interactions. Front Immunol. 2017;7(8):530. doi: 10.3389/fimmu.2017.00530.

Carneiro L, Geller S, Hébert A, et al. Hypothalamic sensing of ketone bodies after prolonged cerebral exposure leads to metabolic control dysregulation. Sci Rep. 2016;6:34909. doi: 10.1038/srep34909.



How to Cite

Syniachenko, O., Fedorov, D., Yermolaieva, M., & Pylypenko, V. (2021). Clinical and pathogenetic importance of hormonal natriuretic peptides in gout. INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine), 14(5), 476–482.



Original Researches

Most read articles by the same author(s)